Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
Yahoo
Thursday, May 7, 2009 - 6:20am
tags:
FDA, Vanda, schizophrenia, Fanapt
Access Pharma: Low Valuation, Big Potential
Seeking Alpha
Thursday, May 7, 2009 - 6:20am
tags:
Access Pharmaceuticals
Group wants boxed warning on constipation drug
Yahoo/AP
Thursday, May 7, 2009 - 6:18am
tags:
constipation, Sucampo, Pfizer, Amitiza
Novartis Puts Its Money Where Its Mouth is, Too
InVivo
Wednesday, May 6, 2009 - 6:13pm
tags:
Novartis, Actonel
Genzyme plans new Lumizyme application in weeks
Yahoo/AP
Wednesday, May 6, 2009 - 6:12pm
tags:
Genzyme, Lumizyme, Pompe disease
Charles River Labs hit by biotech downturn
Bizjournals.com
Wednesday, May 6, 2009 - 6:12pm
tags:
Charles River Laboratories, biotech
Auxilium a Buy at $20
Yahoo/Zacks.com
Wednesday, May 6, 2009 - 6:10pm
tags:
Auxilium, earnings
Acorda Pops On Good News
Yahoo/Zacks.com
Wednesday, May 6, 2009 - 6:09pm
tags:
Acorda Therapeutics, Biogen Idec, Pfizer, Sanofi
CombinatoRx Cuts Deal for Cancer Drug Discovery with Novartis
Xconomy
Wednesday, May 6, 2009 - 10:13am
tags:
CombinatoRx, cancer, partnerships, Novartis
XenoPort: Long-Term Upside
Yahoo/Zacks.com
Wednesday, May 6, 2009 - 9:43am
tags:
GSK, XenoPort
Dendreon pares 1Q loss as research costs decline
Yahoo/AP
Wednesday, May 6, 2009 - 9:40am
tags:
Dendreon, earnings
Par Pharma Q1 profit jumps, shares rise
Reuters
Wednesday, May 6, 2009 - 9:36am
tags:
Par Pharmaceutical, earnings
Solvay Pharmaceuticals wins FDA approval for pancreatic disorder drug
Pharmaceutical Business Review
Wednesday, May 6, 2009 - 8:35am
tags:
Solvay, Creon
Spinning Numbers Tally the Score for Generic Biologics
WSJ Online
Wednesday, May 6, 2009 - 8:34am
tags:
generics, Hospira
Pfizer Bets on Alzheimer's Treatment
Seeking Alpha
Wednesday, May 6, 2009 - 8:31am
tags:
Pfizer, Alzheimer's disease, Aricept, Eisai
Abbott Sues Johnson & Johnson Over New Simponi Drug
Bloomberg
Wednesday, May 6, 2009 - 7:18am
tags:
Abbott Laboratories, JNJ, Simponi, Janssen Biotech
FDA Calendar Updates: Amylin, Alkermes, Eli Lilly, Cell Therapeutics
Seeking Alpha
Wednesday, May 6, 2009 - 7:16am
tags:
Cell Therapeutics, Eli Lilly, FDA, Alkermes, Amylin
Drug maker Lilly to pay Georgia $6 million.Other states file suits over marketing of anti-psychotic drug
AJC,Georgia
Wednesday, May 6, 2009 - 6:17am
tags:
off-label, antipsychotics, settlements, Georgia, Zyprexa
Roche Wins U.S. Approval for Avastin in Brain Cancer
Bloomberg
Wednesday, May 6, 2009 - 6:15am
tags:
Roche, Avastin, brain cancer
Glaxo Sells U.S. Rights to Wellbutrin XL Drug to Biovail for $510 Million
Bloomberg
Wednesday, May 6, 2009 - 6:14am
tags:
GSK, Biovail, Wellbutrin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.